InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the complete record of transactions filed by Quimi Daphne, Chief Financial Officer. Officer active across 1 companies, notably Amicus Therapeutics, INC.. Cumulatively, 5 reports have been recorded. Total volume traded: €38k. The latest transaction was disclosed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€37,5134,396 shares@ €8.53330.0008% mcap14.9% of flow
Common Stock
SEC:0001209191-22-038365:0·
36,840 shares
Common Stock
SEC:0001209191-22-003818·
36,840 shares
Common Stock
SEC:0001209191-22-003818:0·
€107,10610,502 shares@ €10.19870.0024% mcap100.0% of flow
Common Stock
SEC:0001209191-22-001205·
€107,10610,502 shares@ €10.19870.0024% mcap42.5% of flow
Common Stock
SEC:0001209191-22-001205:0·
5 of 5 declarations
About Quimi Daphne
Daphne Quimi serves as Chief Financial Officer of AMICUS THERAPEUTICS, INC. She is responsible for managing the company's finances, including financial planning, risk management, and regulatory compliance. Quimi plays a key role in developing financial strategies that support the growth and profitability of AMICUS THERAPEUTICS.
